What We Know and Don't Know About Merck's COVID Pill

What We Know and Don't Know About Merck's COVID Pill
via AP)

The announcement that a pill from Merck and partner Ridgeback Biotherapeutics kept Covid patients out of the hospital made headlines and moved stocks late last week. But as is so often true when data are released by press release, there are still many questions left unanswered.

Read Full Article »


Comment
Show comments Hide Comments


Related Articles